Report cover image

Global Oncology API Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 128 Pages
SKU # APRC20339516

Description

Summary

According to APO Research, The global Oncology API market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Oncology API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Oncology API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Oncology API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Oncology API include Fresenius Kabi Oncology, Suanfarma, Sterling, Shivalik Rasayan, PROCOS SPA, PolyPeptide, Olon Group, Neopharma and Natco, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology API.
The Oncology API market size, estimations, and forecasts are provided in terms of sales volume (K G) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Oncology API Segment by Company

Fresenius Kabi Oncology
Suanfarma
Sterling
Shivalik Rasayan
PROCOS SPA
PolyPeptide
Olon Group
Neopharma
Natco
Kekule Pharma
Hetero
GLS Pharma
Glenmark Life Sciences
Eisai Pharmaceuticals
Dr. Reddy's
CordenPharma
Concord Biotech
Biocon
Bachem
Aspen API
Aenova
Oncology API Segment by Type

Alkylating Agents
Antimetabolites
Others
Oncology API Segment by Application

Immunotherapy
Chemotherapy
Targeted Therapy
Others
Oncology API Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncology API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oncology API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

128 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Oncology API Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Oncology API Sales Estimates and Forecasts (2020-2031)
1.3 Oncology API Market by Type
1.3.1 Alkylating Agents
1.3.2 Antimetabolites
1.3.3 Others
1.4 Global Oncology API Market Size by Type
1.4.1 Global Oncology API Market Size Overview by Type (2020-2031)
1.4.2 Global Oncology API Historic Market Size Review by Type (2020-2025)
1.4.3 Global Oncology API Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Oncology API Sales Breakdown by Type (2020-2025)
1.5.2 Europe Oncology API Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Oncology API Sales Breakdown by Type (2020-2025)
1.5.4 South America Oncology API Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Oncology API Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Oncology API Industry Trends
2.2 Oncology API Industry Drivers
2.3 Oncology API Industry Opportunities and Challenges
2.4 Oncology API Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Oncology API Revenue (2020-2025)
3.2 Global Top Players by Oncology API Sales (2020-2025)
3.3 Global Top Players by Oncology API Price (2020-2025)
3.4 Global Oncology API Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Oncology API Major Company Production Sites & Headquarters
3.6 Global Oncology API Company, Product Type & Application
3.7 Global Oncology API Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Oncology API Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oncology API Players Market Share by Revenue in 2024
3.8.3 2023 Oncology API Tier 1, Tier 2, and Tier 3
4 Oncology API Regional Status and Outlook
4.1 Global Oncology API Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Oncology API Historic Market Size by Region
4.2.1 Global Oncology API Sales in Volume by Region (2020-2025)
4.2.2 Global Oncology API Sales in Value by Region (2020-2025)
4.2.3 Global Oncology API Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Oncology API Forecasted Market Size by Region
4.3.1 Global Oncology API Sales in Volume by Region (2026-2031)
4.3.2 Global Oncology API Sales in Value by Region (2026-2031)
4.3.3 Global Oncology API Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Oncology API by Application
5.1 Oncology API Market by Application
5.1.1 Immunotherapy
5.1.2 Chemotherapy
5.1.3 Targeted Therapy
5.1.4 Others
5.2 Global Oncology API Market Size by Application
5.2.1 Global Oncology API Market Size Overview by Application (2020-2031)
5.2.2 Global Oncology API Historic Market Size Review by Application (2020-2025)
5.2.3 Global Oncology API Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Oncology API Sales Breakdown by Application (2020-2025)
5.3.2 Europe Oncology API Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Oncology API Sales Breakdown by Application (2020-2025)
5.3.4 South America Oncology API Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Oncology API Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Fresenius Kabi Oncology
6.1.1 Fresenius Kabi Oncology Comapny Information
6.1.2 Fresenius Kabi Oncology Business Overview
6.1.3 Fresenius Kabi Oncology Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Fresenius Kabi Oncology Oncology API Product Portfolio
6.1.5 Fresenius Kabi Oncology Recent Developments
6.2 Suanfarma
6.2.1 Suanfarma Comapny Information
6.2.2 Suanfarma Business Overview
6.2.3 Suanfarma Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Suanfarma Oncology API Product Portfolio
6.2.5 Suanfarma Recent Developments
6.3 Sterling
6.3.1 Sterling Comapny Information
6.3.2 Sterling Business Overview
6.3.3 Sterling Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sterling Oncology API Product Portfolio
6.3.5 Sterling Recent Developments
6.4 Shivalik Rasayan
6.4.1 Shivalik Rasayan Comapny Information
6.4.2 Shivalik Rasayan Business Overview
6.4.3 Shivalik Rasayan Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shivalik Rasayan Oncology API Product Portfolio
6.4.5 Shivalik Rasayan Recent Developments
6.5 PROCOS SPA
6.5.1 PROCOS SPA Comapny Information
6.5.2 PROCOS SPA Business Overview
6.5.3 PROCOS SPA Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 PROCOS SPA Oncology API Product Portfolio
6.5.5 PROCOS SPA Recent Developments
6.6 PolyPeptide
6.6.1 PolyPeptide Comapny Information
6.6.2 PolyPeptide Business Overview
6.6.3 PolyPeptide Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 PolyPeptide Oncology API Product Portfolio
6.6.5 PolyPeptide Recent Developments
6.7 Olon Group
6.7.1 Olon Group Comapny Information
6.7.2 Olon Group Business Overview
6.7.3 Olon Group Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Olon Group Oncology API Product Portfolio
6.7.5 Olon Group Recent Developments
6.8 Neopharma
6.8.1 Neopharma Comapny Information
6.8.2 Neopharma Business Overview
6.8.3 Neopharma Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Neopharma Oncology API Product Portfolio
6.8.5 Neopharma Recent Developments
6.9 Natco
6.9.1 Natco Comapny Information
6.9.2 Natco Business Overview
6.9.3 Natco Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Natco Oncology API Product Portfolio
6.9.5 Natco Recent Developments
6.10 Kekule Pharma
6.10.1 Kekule Pharma Comapny Information
6.10.2 Kekule Pharma Business Overview
6.10.3 Kekule Pharma Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Kekule Pharma Oncology API Product Portfolio
6.10.5 Kekule Pharma Recent Developments
6.11 Hetero
6.11.1 Hetero Comapny Information
6.11.2 Hetero Business Overview
6.11.3 Hetero Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hetero Oncology API Product Portfolio
6.11.5 Hetero Recent Developments
6.12 GLS Pharma
6.12.1 GLS Pharma Comapny Information
6.12.2 GLS Pharma Business Overview
6.12.3 GLS Pharma Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GLS Pharma Oncology API Product Portfolio
6.12.5 GLS Pharma Recent Developments
6.13 Glenmark Life Sciences
6.13.1 Glenmark Life Sciences Comapny Information
6.13.2 Glenmark Life Sciences Business Overview
6.13.3 Glenmark Life Sciences Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Glenmark Life Sciences Oncology API Product Portfolio
6.13.5 Glenmark Life Sciences Recent Developments
6.14 Eisai Pharmaceuticals
6.14.1 Eisai Pharmaceuticals Comapny Information
6.14.2 Eisai Pharmaceuticals Business Overview
6.14.3 Eisai Pharmaceuticals Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Eisai Pharmaceuticals Oncology API Product Portfolio
6.14.5 Eisai Pharmaceuticals Recent Developments
6.15 Dr. Reddy's
6.15.1 Dr. Reddy's Comapny Information
6.15.2 Dr. Reddy's Business Overview
6.15.3 Dr. Reddy's Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Dr. Reddy's Oncology API Product Portfolio
6.15.5 Dr. Reddy's Recent Developments
6.16 CordenPharma
6.16.1 CordenPharma Comapny Information
6.16.2 CordenPharma Business Overview
6.16.3 CordenPharma Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.16.4 CordenPharma Oncology API Product Portfolio
6.16.5 CordenPharma Recent Developments
6.17 Concord Biotech
6.17.1 Concord Biotech Comapny Information
6.17.2 Concord Biotech Business Overview
6.17.3 Concord Biotech Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Concord Biotech Oncology API Product Portfolio
6.17.5 Concord Biotech Recent Developments
6.18 Biocon
6.18.1 Biocon Comapny Information
6.18.2 Biocon Business Overview
6.18.3 Biocon Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Biocon Oncology API Product Portfolio
6.18.5 Biocon Recent Developments
6.19 Bachem
6.19.1 Bachem Comapny Information
6.19.2 Bachem Business Overview
6.19.3 Bachem Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Bachem Oncology API Product Portfolio
6.19.5 Bachem Recent Developments
6.20 Aspen API
6.20.1 Aspen API Comapny Information
6.20.2 Aspen API Business Overview
6.20.3 Aspen API Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Aspen API Oncology API Product Portfolio
6.20.5 Aspen API Recent Developments
6.21 Aenova
6.21.1 Aenova Comapny Information
6.21.2 Aenova Business Overview
6.21.3 Aenova Oncology API Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Aenova Oncology API Product Portfolio
6.21.5 Aenova Recent Developments
7 North America by Country
7.1 North America Oncology API Sales by Country
7.1.1 North America Oncology API Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Oncology API Sales by Country (2020-2025)
7.1.3 North America Oncology API Sales Forecast by Country (2026-2031)
7.2 North America Oncology API Market Size by Country
7.2.1 North America Oncology API Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Oncology API Market Size by Country (2020-2025)
7.2.3 North America Oncology API Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Oncology API Sales by Country
8.1.1 Europe Oncology API Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Oncology API Sales by Country (2020-2025)
8.1.3 Europe Oncology API Sales Forecast by Country (2026-2031)
8.2 Europe Oncology API Market Size by Country
8.2.1 Europe Oncology API Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Oncology API Market Size by Country (2020-2025)
8.2.3 Europe Oncology API Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Oncology API Sales by Country
9.1.1 Asia-Pacific Oncology API Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Oncology API Sales by Country (2020-2025)
9.1.3 Asia-Pacific Oncology API Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Oncology API Market Size by Country
9.2.1 Asia-Pacific Oncology API Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Oncology API Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Oncology API Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Oncology API Sales by Country
10.1.1 South America Oncology API Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Oncology API Sales by Country (2020-2025)
10.1.3 South America Oncology API Sales Forecast by Country (2026-2031)
10.2 South America Oncology API Market Size by Country
10.2.1 South America Oncology API Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Oncology API Market Size by Country (2020-2025)
10.2.3 South America Oncology API Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Oncology API Sales by Country
11.1.1 Middle East and Africa Oncology API Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Oncology API Sales by Country (2020-2025)
11.1.3 Middle East and Africa Oncology API Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Oncology API Market Size by Country
11.2.1 Middle East and Africa Oncology API Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Oncology API Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Oncology API Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Oncology API Value Chain Analysis
12.1.1 Oncology API Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Oncology API Production Mode & Process
12.2 Oncology API Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Oncology API Distributors
12.2.3 Oncology API Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.